Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-06-03T18:17:08.443Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuropsychological and Glucose Metabolic Profiles in Asymmetric Parkinson’s Disease

Published online by Cambridge University Press:  18 September 2015

Erich Mohr ,
Ulrike M. Mann ,
Robert S. Miletich ,
Margaret Sampson ,
Terry E. Goldberg ,
J. David Crimes  and
Thomas N. Chase
Erich Mohr*
Affiliation:
Institute of Mental Health Research, University of Ottawa, Ottawa
Ulrike M. Mann
Affiliation:
University of Hamburg, University Hospital Eppendorf, Department of Neurology, Hamburg, Federal Republic of Germany
Robert S. Miletich
Affiliation:
National Institutes of Health, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland
Margaret Sampson
Affiliation:
Institute of Mental Health Research, University of Ottawa, Ottawa
Terry E. Goldberg
Affiliation:
National Institutes of Health, National Institute of Mental Health, St. Elisabeth Hospital, Washington, D.C.
J. David Crimes
Affiliation:
Loeb Institute for Medical Research, University of Ottawa, Ottawa
Thomas N. Chase
Affiliation:
Institute of Mental Health Research, University of Ottawa, Ottawa
*
Institute of Mental Health Research, 1145 Carling Avenue, Ottawa, Ontario, Canada K1Z 7K4
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Patients with predominantly unilateral parkinsonian signs may provide a unique opportunity to evaluate the cerebral representation of cognitive functions characteristically affected in idiopathic Parkinson’s disease. Twenty hemiparkinsonian patients (ten left and ten right) and 10 healthy controls, matched for age and education, were studied with neuropsychological tests and positron emission tomography. Both right and left hemiparkinsonians evidenced impairments in visuospatial and verbal episodic memory function, but had no deficits in executive abilities, compared to controls. None of the neuropsychological test scores distinguished right from left hemiparkinsonians. Glucose metabolic profiles were identical for the three groups in all cortical areas assessed; in the subcortex however, lenticular hypermetabolism contralateral to the predominant side of motor involvement was evident in the left hemiparkinsonian group. Correlational analysis revealed that higher glucose metabolic rates in the basal ganglia of these hemiparkinsonians were associated with lower visuospatial test scores. In frontal and parietal cortex, decreasing glucose metabolism was positively associated with neurobehavioral function; in temporal cortex, measures of attention and memory decreased with increasing glucose metabolic rates.

Type
Articles
Information
Canadian Journal of Neurological Sciences , Volume 19 , Issue 2 , May 1992 , pp. 163 - 169
Copyright
Copyright © Canadian Neurological Sciences Federation 1992

References

1.Morris, RG, Downes, JJ, Sahakian, BJ, et al. Planning and spatial working memory in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988; 51:757–766.CrossRefGoogle ScholarPubMed
2.Brown, RG, Marsden, CD.Neuropsychology and cognitive function in Parkinson’s disease: an overview. In: Marsden, CD, Fahn, S, eds. Movement Disorders 2, London: Butterworths 1987; 99–123.Google Scholar
3.Mohr, E, Fabbrini, G, Ruggiere, S, Fedio, P, Chase, TN.Cognitive concomitants of dopamine system stimulation in Parkinsonian patients. J Neurol Neurosurg Psychiatry 1987; 50: 1192–1196.CrossRefGoogle ScholarPubMed
4.Mohr, E, Fabbrini, G, Williams, J, et al. Dopamine and memory function in Parkinson’s disease. Mov Disord 1989; 4: 113–120.CrossRefGoogle ScholarPubMed
5.Brown, R, Marsden, C.Visuospatial function in Parkinson’s disease. Brain 1986; 109:987–1002.CrossRefGoogle ScholarPubMed
6.Taylor, AE, Saint-Cyr, JA, Lang, AE.Frontal lobe dysfunction in Parkinson’s disease. Brain 1986; 109: 845–883.CrossRefGoogle ScholarPubMed
7.Brown, RG, Marsden, CD.Subcortical dementia: the neuropsychological evidence. Neuroscience 1988; 25: 363–387.CrossRefGoogle ScholarPubMed
8.Brown, RG, Marsden, CD.An investigation of the phenomenon of “Set” in Parkinson’s disease. Mov Disord 1988; 3: 152–161.CrossRefGoogle ScholarPubMed
9.Mohr, E, Juncos, J, Cox, C, et al. Selective deficits in cognition and memory in high functioning Parkinson’s patients. J Neurol Neurosurg Psychiatry 1990; 53: 603–606.CrossRefGoogle Scholar
10.Boiler, F, Passafiume, D, Keefe, N, et al. Visuospatial impairment in Parkinson’s disease: role of perceptual and motor factors. Arch Neurol 1984; 41:485–490.CrossRefGoogle Scholar
11.Mortimer, JA, Pirozzolo, FJ, Hansch, EC, Webster, DD.Relationship of motor symptoms to intellectual deficits in Parkinson disease. Neurology 1982; 32: 133–137.CrossRefGoogle ScholarPubMed
12.Flowers, KA, Pearce, I, Pearce, JMS.Recognition memory in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1984; 47: 1174–1181.CrossRefGoogle ScholarPubMed
13.Taylor, AE, Saint-Cyr, JA, Lang, AE.Memory and learning in early Parkinson’s disease: evidence for a “frontal lobe syndrome”. Brain Cogn; In Press.Google Scholar
14.Weingartner, H, Burns, S, Diebel, R, LeWitt, PA.Cognitive impairments in Parkinson’s disease: distinguishing between effortdemanding and automatic cognitive processes. Psychiatry Res 1984; 11:223–235.CrossRefGoogle ScholarPubMed
15.Hoehn, MM, Yahr, MD.Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–442.CrossRefGoogle ScholarPubMed
16.Martinez, AJ, Utterback, RA.Unilateral Parkinson’s disease, clinical and neuropathologic findings: a case report. Neurology 1973; 23: 164–170.CrossRefGoogle ScholarPubMed
17.Barolin, GS, Bernheimer, H, Hornykiewicz, O.Seitenverschiedenes Verhalten des Dopamins im Gehirn eines Falles von Hemiparkinsonismus. Schweiz Arch Neurol Psychiatr 1964; 94: 241–248.Google Scholar
18.Huber, SJ, Freidenberg, DL, Shuttleworth, EC, Paulson, GW, Clapp, LE.Neuropsychological similarities in lateralized parkinsonism. Cortex 1989; 25:461–470.CrossRefGoogle ScholarPubMed
19.Blonder, LX, Gur, RE, Gur, RC.The effects of right and left hemiparkinsonism on prosody. Brain Lang 1989; 36: 193–207.CrossRefGoogle ScholarPubMed
20.Spicer, KB, Roberts, RJ, LeWitt, A.Neuropsychological performance in lateralized parkinsonism. Arch Neurol 1988; 45: 429–432.CrossRefGoogle ScholarPubMed
21.Direnfeld, LK, Albert, ML, Volicer, L, et al. Parkinson’s disease: the possible relationship of laterality to dementia and neurochemical findings. Arch Neurol 1984; 41: 935–941.CrossRefGoogle ScholarPubMed
22.Zetusky, WJ, Jankovic, J.Laterality and symptom association in Parkinson’s disease. Arch Neurol 1985; 42: 1132.CrossRefGoogle ScholarPubMed
23.Garnett, ES, Nahmias, C, Firnau, G.Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography. Can J Neurol Sci 1984; 11: 174–179.CrossRefGoogle ScholarPubMed
24.Martin, WRW, Stoessl, AJ, Adam, MJ, et al. Positron emission tomography in Parkinson’s disease: glucose and dopa metabolism. Arch Neurol 1986; 45: 95–98.Google Scholar
25.Fahn, S, Marsden, CD, Calne, DB, Goldstein, M.Recent developments in Parkinson’s disease, New Jersey: Macmillan Health Care Information 1987: 293–304.Google Scholar
26.Wechsler, D.Wechsler Adult Intelligence Scale-Revised, New York: The Psychological Corporation 1981.Google Scholar
27.Wechsler, D, Stone, CP.Wechsler Memory Scale, New York: The Psychological Corporation 1945.Google Scholar
28.Mattis, S.Mental status examination for organic mental syndrome in the elderly. In: Bellack, L, Karasu, TB, eds. Geriatric Psychiatry, New York: Grune and Stratton 1976: 77–121.Google Scholar
29.Heaton, RK.A Manual for the Wisconsin Card Sorting Test, Odessa: Psychological Assessment Resources, Inc. 1981.Google Scholar
30.Kapur, N, Butters, N.Visuoperceptive deficits in long-term alcoholics and alcoholics with Korsakoff’s psychosis. J Stud Alcohol 1977; 38:2025–2035.CrossRefGoogle ScholarPubMed
31.Benton, AL, Hamsher, KD.Multilingual Aphasia Examination, Iowa City: University of Iowa Press 1976.Google Scholar
32.Mosaics Comparison Test. In: Comparative Guidelines and Placement Programs, New Jersey: College Entrance Examination Board, ETS 1972.Google Scholar
33.Raven, JC.Guide to Using the Coloured Progressive Matrices, London: HK Lewis 1965.Google Scholar
34.Money, JA.Standardized Road Map of Direction Sense, San Rafael, CA: Academic Therapy Publications 1976.Google Scholar
35.Osterrieth, PA.Le test de copie d’une figure complexe: contribution l’étude de la perception et de la memoire. Archives de Psychologie 1944; 30: 206–365.Google Scholar
36.Rey, A.L’examen psychologique dans les cas d’encephalopathie traumatique. Archives de Psychologie 1941: 286–340.Google Scholar
37.Woodcock, RWL, Johnson, BW.Woodcock-Johnson Psychoeducational Battery, Boston: Teaching Resources Corp. 1977.Google Scholar
38.Beck, AT, Ward, CH, Mendelson, M, Mock, J, Erbaugh, J.An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–571.CrossRefGoogle ScholarPubMed
39.Foster, NL, Chase, TN, Fedio, P, et al. Alzheimer’s disease: focal cortical changes shown by positron emission tomography. Neurology 1983; 33:961–965.CrossRefGoogle ScholarPubMed
40.Brooks, RA, Sank, VJ, Di Chiro, G, Friauf, WS, Leighton, SB.Design of a high resolution positron emission tomograph: the neuro-PET. J Comput Assist Tomogr 1980; 4: 5–13.CrossRefGoogle ScholarPubMed
41.Brooks, RA, Friquf, WS, Sank, VJ, et al. Initial evaluation of a high resolution Positron Emission Tomograph. In: Greitz, T, Ingvar, DH, Widen, L, eds. The Metabolism of the Human Brain Studied with Positron Emission Tomography, New York: Raven Press 1985: 57–68.Google Scholar
42.Aquilonius, SM, Eckernas, SA.A Colour Atlas of the Human Brain, New York: Raven Press 1980.Google Scholar
43.Brooks, RA.Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med 1982; 23: 538–539.Google ScholarPubMed
44.Freedman, M, Oscar-Berman, M.Selective delayed response deficits in Parkinson’s and Alzheimer’s disease. Arch Neurol 1986; 43: 886–890.CrossRefGoogle ScholarPubMed
45.Gotham, AM, Brown, RG, Marsden, CD.‘Frontal’ cognitive functions in patients with Parkinson’s disease ‘on’ and ‘off levodopa. Brain 1988; 111:299–321.CrossRefGoogle ScholarPubMed
46.Brown, RG, Marsden, CD.Internal versus external cues and the control of attention in Parkinson’s disease. Brain 1988; 111: 323–345.CrossRefGoogle ScholarPubMed
47.Starkstein, S, Leiguarda, R, Gershanik, O.Berthier, M.Neuropsychological disturbances in hemiparkinson’s disease. Neurology 1987; 37: 1762–1764.CrossRefGoogle ScholarPubMed
48.Trasy, D.Interactions between acetylcholine and dopamine in the basal ganlia. In: Davis, KL, Berger, PA, eds. Brain Acetylcholine and Neuropsychiatric Disease, New York: Plenum Press 1979: 395–424.Google Scholar
49.Hornykiewicz, O, Kish, SJ.Biochemical pathophysiology of Parkinson’s disease. Adv Neurol 1986; 45: 19–34.Google Scholar
50.Lloyd, KG, Hornykiewicz, O.Occurrence and distribution of aromatic acid (L-dopa) decarboxylase in human brain. J Neurochem 1972; 19: 1549–1559.CrossRefGoogle ScholarPubMed
51.Mohr, E, Brouwers, P, Claus, JJ, et al. Visuospatial cognition in Huntington’s disease. Mov Disord 1991; 6: 127–132.CrossRefGoogle ScholarPubMed